Dye, OD, details exciting new trials for amblyopia that are in the works at NYU Langone Eye Center.
Colleen Dye, OD
Advertisement
Articles by Colleen Dye, OD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
FDA approves Outlook Therapeutics' Lytenava for wet AMD
2
Frantz EyeCare reports high refractive accuracy with Light Adjustable Lens
3
i-Lumen Scientific enrolls first US patient in i-SIGHT2 pivotal trial of i-Lumen AMD System
4
Rethinking OCT biomarkers in DME: Baseline acuity and thickness outperform the rest
5